Form 4: Director Shawn McCormick Sells Inspire Medical Systems Stock

Director Shawn McCormick reported a sale of Inspire Medical Systems Inc. common stock valued at approximately $31,550, executed under a pre-arranged trading plan.

Summary

• Director Shawn McCormick sold 696 shares of Inspire Medical Systems, Inc. common stock on May 8, 2026.
• The transaction was executed at a price of $45.31 per share, totaling $31,550.86.
• These shares were sold directly, and McCormick's direct beneficial ownership following the transaction is 27,712 shares.
• Additionally, McCormick beneficially owns 3,000 shares held in a trust.
• The sale was conducted under a Rule 10b5-1 trading plan established on August 29, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction was conducted under a pre-established 10b5-1 plan, indicating a planned sale rather than a reaction to current company performance.

Negatives

• Director Shawn McCormick sold a portion of his direct holdings in the company.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 plan, are common and often reflect pre-determined diversification or liquidity strategies rather than a negative view of the company's prospects. However, significant sales by directors can sometimes be interpreted by the market as a signal.

Stakeholder Impact

• Shareholders may note the sale by a director, but the use of a 10b5-1 plan suggests it was pre-planned and not necessarily a reflection of negative sentiment towards the company's future performance.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, Inspire Medical Systems, Shawn McCormick, Rule 10b5-1, Director Transaction